Mid-market private equity house LDC has funded the GBP30 million merger of three cloud-based managed services businesses – DoubleEdge Professional Services, Foehn and Metaphor IT – to form Kerv.
LGT Capital Partners ESG Report 2020 reveals that 81 per cent of private equity managers already integrate ESG into their investment process, and a large part of the focus is shifting toward climate awareness. According to Keimpe Keuning, executive director at LGT Capital Partners and one of the authors of LGT’s
Evolution Equity Partners has led a Series C round in Quantexa, a decision intelligence software company that enables organisations to make better decisions, raising a further USD64.7 million in funding.
London-based growth investor SFC Capital has led a GBP 500,000 seed round for biotechnology startup Novai, a product of University College London. Founded by Professor Francesca Cordeiro from UCL and Imperial College London and headquartered in London, Novai was created through Wellcome Trust funding. The fresh capital will be used
Central Europe’s private equity markets are feeling the impact of Covid-19 – but there is more optimism than during the 2008 Global Financial Crisis, suggesting the experience the region’s deal-doers have accumulated may buoy investments and create a basis for new deals, according to the latest Deloitte Central Europe Private
RedBird Capital Partners has entered into a definitive agreement with Toulouse FC to acquire an 85 per cent majority stake in the French Ligue 2 football club. Toulouse FC was relegated, along with Amiens, from the top tier of French football in April when clubs voted to end the season early due to the
Vital Capital has partnered up with the US Government’s Kenya Investment Mechanism to provide funding to Kenyan agri-businesses that have been affected by the Covid-19 pandemic. Vital Capital is an impact investment private equity fund focused on companies in sub-Saharan Africa. “We are excited to launch this major collaboration to
London-based financial firms appear to be in no rush to have the majority of their staff back in the office, according to new research by Theta Financial Reporting. Only 800 of Goldman Sachs’s 6,000 London staff have returned, while fewer than 2,000 of the 12,000 at JP Morgan are back in the office,
British Patient Capital has invested USD65 million in SV Health Investors’s USD265 million fund, SV7 Impact Medicine Fund (IMF), which is dedicated to investing in biotech companies. The IMF is SV’s first biotech fund. It will aim to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs
CommerzVentures has made a USD6 million investment into Concirrus, a speciality analytics insurtech company. This latest investment by CommerzVentures follows a recent announcement which saw London-based VC firm AlbionVC lead on a USD 20 million series B funding round, which included participation from current investors IQ Capital and EOS Venture
09 October, 2024 – 8:30 am
14 November, 2024 – 5:00 pm
09 October, 2024 – 5:00 pm
09 October, 2024 – 6:00 pm
